Logo image
Role of NADPH oxidase and xanthine oxidase in mediating inducible VT/VF and triggered activity in a canine model of myocardial ischemia
Journal article   Open access   Peer reviewed

Role of NADPH oxidase and xanthine oxidase in mediating inducible VT/VF and triggered activity in a canine model of myocardial ischemia

James B Martins, Ashok K Chaudhary, Shuxia Jiang, Michael Kwofie, Prescott Mackie and Francis J Miller
International journal of molecular sciences, Vol.15(11), pp.20079-20100
11/04/2014
DOI: 10.3390/ijms151120079
PMCID: PMC4264157
PMID: 25375191
url
https://doi.org/10.3390/ijms151120079View
Published (Version of record) Open Access

Abstract

Ventricular tachycardia or fibrillation (VT/VF) of focal origin due to triggered activity (TA) from delayed afterdepolarizations (DADs) is reproducibly inducible after anterior coronary artery occlusion. Both VT/VF and TA can be blocked by reducing reactive oxygen species (ROS). We tested the hypothesis that inhibition of NADPH oxidase and xanthine oxidase would block VT/VF. 69 dogs received apocynin (APO), 4 mg/kg intraveneously (IV), oxypurinol (OXY), 4 mg/kg IV, or both APO and OXY (BOTH) agents, or saline 3 h after coronary occlusion. Endocardium from ischemic sites (3-D mapping) was sampled for Rac1 (GTP-binding protein in membrane NADPH oxidase) activation or standard microelectrode techniques. Results (mean±SE, * p<0.05): VT/VF originating from ischemic zones was blocked by APO in 6/10 *, OXY in 4/9 *, BOTH in 5/8 * or saline in 1/27; 11/16 VT/VFs blocked were focal. In isolated myocardium, TA was blocked by APO (10(-6) M) or OXY (10(-8) M). Rac1 levels in ischemic endocardium were decreased by APO or OXY. APO and OXY suppressed focal VT/VF due to DADs, but the combination of the drugs was not more effective than either alone. Both drugs inhibited ischemic Rac1 with inhibition by OXY suggesting ROS-induced ROS. The inability to totally prevent VT/VF suggests that other mechanisms also contribute to ischemic VT.
Acetophenones - pharmacology Acetophenones - therapeutic use Action Potentials - drug effects Animals Blotting, Western Disease Models, Animal Dogs Female Male Myocardial Ischemia - diagnostic imaging Myocardial Ischemia - drug therapy Myocardial Ischemia - enzymology Myocardial Ischemia - physiopathology NADPH Oxidases - antagonists & inhibitors NADPH Oxidases - metabolism Oxypurinol - pharmacology Oxypurinol - therapeutic use rac1 GTP-Binding Protein - metabolism Tachycardia, Ventricular - complications Tachycardia, Ventricular - drug therapy Tachycardia, Ventricular - enzymology Tachycardia, Ventricular - physiopathology Ultrasonography Ventricular Fibrillation - complications Ventricular Fibrillation - drug therapy Ventricular Fibrillation - enzymology Ventricular Fibrillation - physiopathology Xanthine Oxidase - antagonists & inhibitors Xanthine Oxidase - metabolism

Details

Metrics

Logo image